Oncogenic signalling rewires the translational machinery to support the expression of specific functional classes of pro-tumorigenic genes. An expanding list of structural and sequence-specific ...
Eli Lilly & Co. and Anima Biotech have teamed to develop small-molecule translation inhibitors for undisclosed protein targets. In exchange for a $30 million up-front fee and $14 million in research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results